Next week LGND will also be presenting at a Nuclear Hormone Receptor Conference in Philadelphia (the list of speakers looks like an old Ligand personel directory or current Alliance partners):
July 28-29, 1997 ú The Ritz-Carlton ú Philadelphia, PA
SELECTIVE STEROID RECEPTOR MODULATORS
ESTROGEN RECEPTOR-[beta]
TISSUE SPECIFICITY
TRANSCRIPTIONAL REGULATION
STRUCTURE-ACTIVITY RELATIONSHIPS
DEVELOPING THERAPIES
PROGESTERONE RECEPTORS
FLUORESCENCE POLARIZATION HIGH-THROUGHPUT
SCREENING
COMBINATORIAL LIBRARIES FOR NUCLEAR RECEPTORS
VITAMIN D RECEPTORS AND VITAMIN D ANALOGS
RETINOID RECEPTORS
RETINOID RECEPTOR INVERSE AGONISTS
ORPHAN RECEPTORS AND ORPHAN LIGANDS
CELL-BASED ASSAYS
SPEAKERS
George F. Allan, Ph.D.,
RW Johnson Pharmaceutical
Research Institute
Tom Burke, Ph.D.,
PanVera Corporation
Tauseef R. Butt, Ph.D.,
Technologies, Inc.
Susan Carswell, Ph.D.,
Cephalon, Inc.
John F. Couse, M.S.P.H.,
National Institute of
Environmental Health Sciences
Ethan Dmitrovsky, M.D.,
Memorial Sloan Kettering Cancer
Center
Alex Elbrecht, Ph.D.,
Merck Research Laboratories
Leonard P. Freedman, Ph.D.,
Memorial Sloan Kettering Cancer
Center
Andrew L. Glasebrook, Ph.D.,
Lilly Research Laboratories
Ning Fei Go, M.D.,
Affymax Research Institute
Richard A. Heyman, Ph.D.,
Ligand Pharmaceuticals Inc.
Sotirios K. Karathanasis, Ph.D.,
Wyeth-Ayerst
Elliot S. Klein, Ph.D.,
Allergan, Inc.
Paul N. MacDonald, Ph.D.,
Saint Louis University School of
Medicine
David J. Mangelsdorf, Ph.D.,
Howard Hughes Medical Institute,
University of Texas Southwestern
Medical Center
Donald P. McDonnell, Ph.D.,
Duke University Medical Center
Jeffrey L. Nordstrom, Ph.D.,
GeneMedicine, Inc.
Jacek Ostrowski, Ph.D.,
Bristol-Myers Squibb
Pharmaceutical Research Institute
Alan D. Palkowitz, Ph.D.,
Lilly Research Laboratories
Timothy M. Willson, Ph.D.,
Glaxo Wellcome, Inc.
Details can be found at:
ibcusa.com |
